Patient Perception of Provider Concern Impacts Satisfaction

Share this content:
Patient Perception of Provider Concern Impacts Satisfaction
Patient Perception of Provider Concern Impacts Satisfaction

MONDAY, Jan. 16, 2017 (HealthDay News) -- For patients with chronic pain receiving opioids, provider satisfaction is not associated with functional outcomes; however, patient perception of provider concern impacts perceived satisfaction, according to a study published online Jan. 13 in Pain Practice.

Anthony Dragovich, M.D., from Blue Ridge Pain Management in Salem, Va., and colleagues examined the determinants of patient satisfaction and the correlation with recommended outcome measures in a private practice pain management clinic. Determinants of patient satisfaction were defined using a four-week quality assessment survey among pain management patients who were prescribed opioids.

The researchers found that for a chronic pain population prescribed opioids for over one year, overall provider satisfaction was 96 percent and clinic satisfaction was 94 percent. Provider satisfaction was not associated with functional outcomes. A positive correlation was only seen for "level of stress" with positive clinic satisfaction. The remaining functional outcomes were not associated with satisfaction. Significant predictors of provider satisfaction included "listened to you carefully about your questions and concerns," "treated you with courtesy and respect," and "helped you with your problem."

"These results indicate that a patient's perception of a provider's engagement and concern more heavily impacts perceived satisfaction than the patient's progress," the authors write. "A patient's perception of his or her clinic experience is heavily influenced by the attentiveness and coordination of the entire clinic care team."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »